Answers are grounded in this paper and cite their sources.
INTRODUCTION: Endoscopic ultrasound-guided liver abscess drainage (EUS-LAD) is an alternative to percutaneous catheter drainage (PCD), but comparative evidence remains limited. We evaluated its efficacy and safety using comparative and single-arm studies. METHODS: PubMed, Web of Science, CENTRAL, and Scopus were searched through January 13, 2026. Clinical and technical success were primary outcomes; recurrence, mortality, and adverse events were secondary outcomes. Random-effects meta-analyses pooled comparative risk ratios (RRs) and single-arm proportions. RESULTS: Ten studies involving 501 patients were included. EUS-LAD had higher clinical success [RR: 1.07, 95% CI: (1.01, 1.13); P=0.03] and fewer overall complications [RR: 0.26, 95% CI: (0.12, 0.55); P<0.01] than PCD. No significant differences were found in technical success [RR: 0.99, 95% CI: (0.95, 1.02); P=0.43], mortality [RR: 0.53, 95% CI: (0.10, 2.85); P=0.46], or recurrence [RR: 0.82, 95% CI: (0.29, 2.28); P=0.70]. Single-arm pooled clinical success and complication rates were 98% and 7%, respectively. CONCLUSIONS: EUS-LAD is a promising alternative to PCD, with higher pooled clinical success and fewer overall complications. These findings require cautious interpretation because the evidence is predominantly retrospective and observational.
No takes yet. Share an insight, caveat, or question.
Al-Obaidi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: